← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Stategics, Inc.
South San Francisco, CA
$4,412,652
Total funding
5
Grants
Funding over time
peak $1.7M · FY2008–21$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$2,720,095 · 4
DOD$1,692,557 · 1
By mechanism
R44$2,062,807 · 1
—$1,692,557 · 1
R43$657,288 · 3
Investigators at Stategics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
NEUROPROTECTIVE SMALL-MOLECULE ERYTHROPOIETIN MIMETICS FOR THE TREATMENT OF TRAUMATIC BRAIN INJURY$1,692,557
· FY2011 · Department of Defense
Homogeneous Screening Assay for Cytokine Receptor Modulators$738,401
R44 · FY2020 · TR
Homogeneous Screening Assay for Cytokine Receptor Modulators$722,532
R44 · FY2019 · TR
Homogeneous Screening Assay for Cytokine Receptor Modulators$515,113
R44 · FY2021 · TR
Development of a Homogeneous Screening Assay for the Tissue-Protective EPOR$242,013
R43 · FY2017 · TR
Small Molecule Erythropoietin Receptor Agonists for the Treatment of Acute Kidney$227,624
R43 · FY2013 · DK
Low Molecular Weight Erythropoietin Mimetics For Improved CNS Penetrance And Trea$187,651
R43 · FY2008 · NS
Homogeneous Screening Assay for Cytokine Receptor Modulators$86,761
R44 · FY2021 · TR